EUCTR2016-001835-11-IT进行中（未招募）1 期
A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Subjects with Advanced Non-small Cell Lung Cancer (Master Protocol Revised version 05 dated 16-Feb-2017 + Sub-protocol A Revised version 03 dated 16-Feb-2017+ Sub-protocol B Revised version 01 dated 12-Oct-2018) - FRACTION-Lung
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 295
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •For the master Protocol :
- •-Advanced Non Small Cell Lung Cancer (NSCLC)
- •-ECOG Performance status of = 1
- •-Life expectancy of at least 3 months from most recent chemotherapy or
- •immunotherapy treatment
- •-Must have at least 1 lesion with measurable disease
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 450
排除标准
- •For the master Protocol :
- •-Subjects with certain mutations must have been treated with a targeted therapy prior to enrollment
- •-Must not have suspected or known central nervous system metastases unless adequately treated
- •-Subjects who need daily oxygen therapy
- •-People with autoimmune disease
研究者
相似试验
进行中（未招募）
1 期
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung CancerEUCTR2016-001835-11-ESBristol-Myers Squibb International Corporation1,380
进行中（未招募）
1 期
A Study to Test Combination Treatments in People with Advanced Renal Cell CarcinomaEUCTR2016-003082-26-ITBRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATIO300
进行中（未招募）
1 期
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 19.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-001835-11-FRBristol-Myers Squibb International Corporation295
进行中（未招募）
1 期
A Study to Test Combination Treatments in People With Advanced Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 20.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-001835-11-ATBristol-Myers Squibb International Corporation295
进行中（未招募）
1 期
A Study to Test Combination Treatments in People with Advanced Renal Cell CarcinomaEUCTR2016-003082-26-ATBristol-Myers Squibb International Corporation300